Mpm Oncology Innovations Fund LP insider trades
Mpm Oncology Innovations Fund LP has filed 2 Form 4s with the SEC that we hold, for Aktis Oncology, Inc. (AKTS) (10% owner) and Werewolf Therapeutics, Inc. (HOWL) (10% owner). Across all of them we count 1 purchase worth $20.0M and 3 sales worth $391.6K reported on Form 4. In the last 12 months: 1 purchase ($20.0M) and 3 sales ($391.6K). The largest single trade was a purchase of 1,112,777 shares of Aktis Oncology, Inc. worth $20.0M, dated 2026-01-12. The first filing on our record is dated 2025-11-03 and the latest 2026-01-14.
Aktis Oncology, Inc. (AKTS)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-01-12 | P, purchase reported on Form 4 | 1,112,777 | $20.0M | 2026-01-14 |
Werewolf Therapeutics, Inc. (HOWL)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-10-30 | S, sale reported on Form 4 | 86,936 | $124.3K | 2025-11-03 |
| 2025-10-31 | S, sale reported on Form 4 | 114,044 | $146.0K | 2025-11-03 |
| 2025-11-03 | S, sale reported on Form 4 | 94,063 | $121.3K | 2025-11-03 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1719960) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms